-

Global Contraceptive Drugs Market Report 2023: Increasing Awareness and Acceptance of Contraceptive Drugs Drives Growth - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Global Contraceptive Drugs Market Report and Forecast 2023-2031" report has been added to ResearchAndMarkets.com's offering.

The global contraceptive drugs market size attained a value of USD 17.42 billion in 2022. The market is further expected to grow at a CAGR of 7.02% during the forecast period of 2023-2031 to attain a value of USD 32.08 billion by 2031.

The growth of the market is driven by the increasing awareness and acceptance of contraceptive drugs.

Contraceptive drugs are medications that are used to prevent unwanted pregnancies by suppressing ovulation, altering the cervical mucus to prevent sperm from reaching the egg, or changing the lining of the uterus to prevent implantation. These drugs are available in different forms such as pills, patches, injections, vaginal rings, and implants.

There are two main types of contraceptive drugs: hormonal and non-hormonal. Hormonal contraceptive drugs contain synthetic versions of the female hormones oestrogen and progestin, or progestin alone, which work by inhibiting ovulation. Non-hormonal contraceptive drugs, on the other hand, work by altering the acidity of the cervical mucus or by creating a physical barrier that prevents sperm from reaching the egg.

Contraceptive drugs are widely used by women around the world to prevent unwanted pregnancies and to space out births. They are a safe and effective method of birth control when used correctly, but like any medication, they can have side effects. It is important to talk to a healthcare provider to determine the best contraceptive option based on an individual's medical history, lifestyle, and preferences.

Contraceptive Drugs Market Scenario

The global contraceptive drugs market is expected to experience steady growth in the coming years. This market is driven by the increasing awareness and acceptance of contraceptive drugs as a means of birth control, especially among women.

The market is expected to be driven by various factors such as an increase in the prevalence of unwanted pregnancies and sexually transmitted diseases (STDs), a rise in the number of women in the workforce, and an increase in the availability of contraceptive drugs. Additionally, technological advancements, such as the development of new drugs with fewer side effects, are expected to drive market growth.

Geographically, the market is divided into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The Asia Pacific region is expected to experience the highest growth in the market due to the high population growth rate and increasing awareness of contraceptive drugs among women.

Overall, the global contraceptive drugs market is expected to experience steady growth in the coming years, driven by increasing awareness, technological advancements, and the introduction of new and improved drugs.

Key Players in the Global Contraceptive Drugs Market

The report gives an in-depth analysis of the key players involved in the contraceptive drugs market, sponsors manufacturing the drugs, and putting them through trials to get FDA approvals. The companies included in the market are as follows:

  • Piramal Enterprises Ltd
  • Agile Therapeutics
  • Johnson & Johnson Services, Inc
  • Abbive Inc
  • Merck & Co Inc
  • Teva Pharmaceuticals Industries Ltd
  • Bayer AG
  • Pfizer Inc
  • Helm AG
  • Reckitt Benckiser Group PLC
  • Viatris Inc
  • Amneal Pharmaceuticals LLC
  • Bayer AG
  • Allergan plc
  • Agile Therapeutics

Market Segmentation

by Product Type

  • Contraceptive Drugs
  • Contraceptive Pills
  • Patch
  • Injectables

by Route of Administration

  • Oral
  • Parentals
  • Topicals
  • Others

by Therapy Type

  • Monotherapy
  • Combined Contraceptives

by Age Group

  • 15-45 Years
  • Above 45 Years

by Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Clinics
  • Online Channel
  • Public Channel
  • NGOs, Others

by Region

North America

  • United States of America
  • Canada

Europe

  • United Kingdom
  • Germany
  • France
  • Italy
  • Others

Asia Pacific

  • China
  • Japan
  • India
  • ASEAN
  • Australia
  • Others

Latin America

  • Brazil
  • Argentina
  • Mexico
  • Others

Middle East and Africa

  • Saudi Arabia
  • United Arab Emirates
  • Nigeria
  • South Africa
  • Others

For more information about this report visit https://www.researchandmarkets.com/r/9a2g2o

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Research and Markets


Release Versions

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

Computer System Validation (CSV) Training Course: Regulations Impacting Your Systems and Hands-on Practice Writing Validation Documents (Jan 27th - Jan 29th, 2026 & On-Demand) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Computer System Validation (CSV) Training Course (Jan 27th - Jan 29th, 2026)" training has been added to ResearchAndMarkets.com's offering. A course designed to completely immerse you in computer system validation. This course delivers comprehension of the regulations impacting your systems and hands-on practice writing validation documents. You will leave ready to lead efficient, effective, inspection- ready validation projects. Registration Includes: Checklist of...

Understanding Medical Device Regulatory Pathways - 510(k), PMA & Exemptions Webinar - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Understanding Medical Device Regulatory Pathways - 510(k), PMA & Exemptions (January 15, 2026)" training has been added to ResearchAndMarkets.com's offering. This expert-led 3-hour webinar provides a comprehensive introduction to the key regulatory pathways for medical device submissions in the US market. The regulation and control of new or substantially changed medical devices for sale in the US is based on the 510(k), PMA or DeNovo submission process. This w...

Medical Devices: Section 522 of the Federal Food, Drug, and Cosmetic Act (FD&C Act) Course: Developing Effective Post Market Surveillance and Complaint Handling Systems Training - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Medical Devices: Developing Effective Post Market Surveillance and Complaint Handling Systems Course (Jan 22nd - Jan 23rd, 2026)" training has been added to ResearchAndMarkets.com's offering. What are U.S. FDA CGMP expectations/requirements for Post Market Surveillance and Complaint Handling? This seminar will examine Section 522 of the Federal Food, Drug, and Cosmetic Act (FD&C Act), as well as appropriate articles / Annexes of the EU's MDR, which require manu...
Back to Newsroom